"Oral Simnotrelvir: A Game-Changing COVID Treatment for Adults"
Originally Published 2 years ago — by Nature.com
A new antiviral drug called simnotrelvir has shown promising results in speeding up recovery from mild to moderate COVID-19 symptoms, with a clinical trial demonstrating its effectiveness in reducing SARS-CoV-2 levels in patients. The drug, administered as a series of pills, is priced lower than its main rival, Paxlovid, in China and has been available under emergency use authorization since early last year. While the drug's potency is welcomed, some concerns remain about its taste, compatibility with other medications, and the need for more data on its effectiveness in preventing hospitalization and death in high-risk individuals.